Global Bursitis Treatment Market Growth (Status and Outlook) 2023-2029

Global Bursitis Treatment Market Growth (Status and Outlook) 2023-2029

Bursitis is a swelling or inflammation of the bursa – a sac filled with a lubricating fluid and located between the tissues such as bone, skin, tendons and muscles. Lubricating fluid helps in reducing the friction, rubbing and irritation upon movement of a joint. Bursitis affects mainly elbow, hip, shoulder, knee and Achilles tendon. The most common symptoms of bursitis are pain, swelling and stiffness in affected area. Sudden or severe pain may gradually build up, if there is a presence of calcium deposits. Bursitis is commonly caused by the repetitive trauma of injuries on the affected area. Improper posture at home, work and poor stretching before exercise also lead to bursitis. A poorly or an abnormal placed bone or joint can put extra stress on a bursa sac, causing bursitis. Infection from other conditions such as thyroid disorder gout, or unusual medication reactions also increase a person’s risk for bursitis. Sometimes an infection can sometimes lead to inflammation of a bursa. In adults bursitis is very common especially those over 40 years of age. There are number of ways for bursitis treatment like resting the injured area, icing the area, avoiding activities that aggravate the problem, taking over the counter anti-inflammatory medicines and many more. Surgery may be an option when bursitis does not respond to the other treatment options but it is rarely needed.

LPI (LP Information)' newest research report, the “Bursitis Treatment Industry Forecast” looks at past sales and reviews total world Bursitis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Bursitis Treatment sales for 2023 through 2029. With Bursitis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bursitis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Bursitis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bursitis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bursitis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bursitis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bursitis Treatment.

The global Bursitis Treatment market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The global bursitis treatment market is driven by the increasing geriatric population highly prone to the bone injury. Another factor which can influence the growth of global bursitis market can be rising number of sports related injuries. Moreover, increasing incidence of elbow joint pain and R&D investment by pharmaceutical companies etc. are the factors which are driving the global bursitis market. However, lack of awareness towards bursitis treatment options, low treatment rate due to absence of signs and symptoms of bursitis are some factors limiting the growth of global bursitis treatment market.

This report presents a comprehensive overview, market shares, and growth opportunities of Bursitis Treatment market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Corticosteroids
Antibiotic
Analgesics
Others

Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Teva Pharmaceutical
Crecent Therapeutics
Arinna Lifesciences Private
Sun Pharmaceutical Industries
Bioanalytical Systems
Perrigo Company
Arbor Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.